Daily BriefsTMT/Internet

Daily Brief TMT/Internet: Tata Technologies, Tokai Carbon Korea, Hong Kong Hang Seng Index, ACM Research, Chipmos Technologies, Tencent, Acer Inc and more

In today’s briefing:

  • Tata Technologies IPO: The Bear Case
  • A Long Short Trading Event Likely to Have a High Hit Rate: HPSP & TCK
  • EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades- Peak Rates?
  • [ACM Research (ACMR US)]: Preferred Local Tool Supplier Beginning Global Ascent
  • ChipMOS Industry View: Display Downturn Rebounding, Memory Delayed, Guidance Proving Prescient
  • ECM Weekly (7th May 2023) – Mankind, Nexus REIT, Pertamina Hulu, Growatt, DXN, Giant Biogene, Ventia
  • Acer Q1’23 Revenue NT$52.46 Billion, -12% QoQ, -33% YoY.

Tata Technologies IPO: The Bear Case

By Arun George

  • Tata Technologies (TATATECH IN), the largest India-based ER&D (engineering research and development) service provider, is seeking to raise up to US$600 million, according to press reports.
  • In Tata Technologies IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The key elements of the bear case rest on below-peer revenue growth, high contract assets, growth reliant on VinFast, mid-tier profitability, and high attrition rates.   

A Long Short Trading Event Likely to Have a High Hit Rate: HPSP & TCK

By Sanghyun Park

  • The Korean local sector ETF with the fastest growing AUM is TIGER Fn Semiconductor Top 10 ETF, whose AUM has increased more than twice over the past two months.
  • HPSP (403870 KS) will replace Tokai Carbon Korea (064760 KS) by a comfortable margin in the upcoming review in October.
  • From a day trading perspective, this presents a significant Long-Short opportunity. Considering the relatively sizeable passive impact size, setting an entry point more aggressively may not be a bad idea.

EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades- Peak Rates?

By Simon Harris

  • Weekly summary of vol changes and moves across Global Markets
  • Analysing ATM volatility and skew changes over the last 5 days
  • We suggest a few trades to take advantage of the implied vol surfaces

[ACM Research (ACMR US)]: Preferred Local Tool Supplier Beginning Global Ascent

By Shawn Yang

  • ACMR reported C1Q23 top-line, GAAP EBIT and non-IFRS net profit (2.8%), 42% and 35% vs. our est., and in-line, and positive vs. negative, respectively. 
  • We estimate ACMR’s China wafer clean/ECD share was 11%/45%~ in 1Q23, +4/28ppts YoY, while guidance implies 45%/50%~ in 4Q23, respectively; 
  • We maintain BUY and US$ 30 TP, implying 2.0x FY24 EV/Sales

ChipMOS Industry View: Display Downturn Rebounding, Memory Delayed, Guidance Proving Prescient

By Vincent Fernando, CFA

  • Chipmos Technologies (8150 TT) reported results last week, beating expectations and showing an increase in capacity utilization QoQ.
  • The company reported notable strength in Display Driver related demand, and capacity utilization for the segment may have bottomed back in 3Q22.
  • Memory is expected to have a delayed recovery according to ChipMOS, potentially coming in 3Q23. Adjusted our model — We continue to believe ChipMOS is cheap through the cycle.

ECM Weekly (7th May 2023) – Mankind, Nexus REIT, Pertamina Hulu, Growatt, DXN, Giant Biogene, Ventia

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • Nexus Select Trust will open books for India’s first Retail REIT, just as the first major India IPO for the year, Mankind Pharma seeks to list.
  • There was only Ventia (VNT AU) placement during the week, along with Giant Biogene Holding (2367 HK) lockup expiry.

Acer Q1’23 Revenue NT$52.46 Billion, -12% QoQ, -33% YoY.

By William Keating

  • Q1’23 was Acer’s fifth consecutive quarter of sequentially declining revenues
  • Called Q1’23 the trough but no specific guidance on the current quarter
  • Chromebook sales surged 44.4% QoQ. What was the reason for this?

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars